... from a patient with systemiclupuserythematosus (a) Anti-FDC (follicular dendritic cell) staining within the area known as germinal centre (GC) A (b) Staining for CD20 FDC staining suggests two ... mutations within the CDRs, of which the most prevalent was from serine to asparagine; other mutations included serine to threonine, tyrosine, aspartate, methionine and proline Discussion The immunohistology ... cells The aims of the present study were to identify the immunoglobulin V genes used by proliferating B cell clones in GCs of a SLE spleen, and to determine whether there are abnormalities in the...
... Takeda T, Inoue T: Serum levels of interferons in patients with systemiclupuserythematosus Clin Exp Immunol 1987, 70:562-569 Hooks JJ, Moutsopoulos HM, Notkins AL: Circulating interferon in human ... N, Winchester RJ: The 1982 revised criteria for the classification of systemiclupuserythematosus Arthritis Rheum 1982, 25:1271-1277 Gladman DD, Ibanez D, Urowitz MB: Systemiclupuserythematosus ... background of systemiclupus erythematosus: insights from Asia Autoimmunity 2005, 38:347-352 Means TK, Luster AD: Toll-like receptor activation inthe pathogenesis of systemiclupus erythematosus...
... cardiovascular risk factors insystemiclupuserythematosus J Musculoskel Med 1998, 15: 42-52 El-Magadmi M, Ahmad Y, Wajed J, Bruce IN: The bimodal mortality pattern insystemiclupuserythematosus Curr ... factors of carotid plaque in women with systemiclupuserythematosus Arthritis Rheum 1999, 42:51-60 Salmon JE, Roman MJ: Accelerated atherosclerosis insystemiclupus erythematosus: implications ... Kong TQ, Kellum RE, Haserick JR: Clinical diagnosis of cardiac involvement insystemiclupus erythematosus: a correlation of clinical and autopsy findings in thirty patients Circulation 1962,...
... iodide staining, according to the method of Nicoletti and colleagues [19], and by the binding of FITCconjugated Annexin V, using the Apoptest binding kit, containing annexin V-FITC and binding buffer ... manifestations other than anxiety Differences between the groups as measured by the χ2 test were not statistically significant SLE, systemiclupus erythematosus; SLEDAI, SystemicLupusErythematosus ... 10 at 4°C and then soaked in balanced salt solution (Sigma) for 30 at 25°C Cells were then incubated for 30 at 25°C inthe blocking buffer (2% bovine serum albumin in PBS, containing 5% glycerol...
... proteins and DNA by high NaCl and possibly secondary conformational changes help the binding of anti-RPA antibodies in autoimmune sera We examined whether the binding of DNA to RPA can interfere the ... ELISA with the recombinant RPA32 protein Antibodies against RPA32 were found in 10.9% (87 of 801) in breast cancer patients and in 10.3% (4 of 39) in intraductal in situ carcinoma patients, in contrast ... autoantibodies by incubating affinity-purified RPA with ssDNA, dsDNA, or dsRNA before antibody binding When the RPA was incubated with ssDNA or dsDNA before the reaction with autoimmune sera, the binding of...
... blockade in patients with systemiclupuserythematosus While dampening inflammation, TNF blockade with infliximab induced an increase of autoantibodies in five out of seven patients and increases in ... on infliximab therapy in SLE suggests that, in combination with azathioprine, infliximab may turn out to be an interesting therapeutic option in selected patients with SLE and in particular in ... activity insystemiclupuserythematosus Clin Rheumatol 1999, 18:17-22 44 Aringer M, Stummvoll GH, Steiner G, Koller M, Steiner CW, Hofler E, Hiesberger H, Smolen JS, Graninger WB: Serum interleukin-15...
... Takeda T, Inoue T: Serum levels of interferons in patients with systemiclupuserythematosus Clin Exp Immunol 1987, 70:562-569 Hooks JJ, Moutsopoulos HM, Notkins AL: Circulating interferon in human ... N, Winchester RJ: The 1982 revised criteria for the classification of systemiclupuserythematosus Arthritis Rheum 1982, 25:1271-1277 Gladman DD, Ibanez D, Urowitz MB: Systemiclupuserythematosus ... background of systemiclupus erythematosus: insights from Asia Autoimmunity 2005, 38:347-352 Means TK, Luster AD: Toll-like receptor activation inthe pathogenesis of systemiclupus erythematosus...
... responding to immunosuppressive therapy inlupus patients should raise suspicion of alternative diagnoses such as PVNS Page of Competing interests The authors declare that they have no competing interests ... the synovial fluid effusion (white) inthe dorsal recessus of the joint around the femoral head (B) Gadolinium contrast of sagittal images shows diffuse enhancement in synovial tissue along the ... markers in proliferating synovial cells Histopathology 2005, 46:490-497 doi:10.1186/1752-1947-5-443 Cite this article as: Anders: Pigmented villonodular synovitis of the hip insystemiclupus erythematosus: ...
... C-reactive protein insystemiclupuserythematosusLupus 2009, 18:966-973 44 McMahon M, Hahn BH: Atherosclerosis and systemiclupuserythematosus - mechanistic basis of the association Curr Opin Immunol ... assessment and treatment insystemiclupuserythematosus Best Practice Res Clin Rheumatol 2009, 23:481-494 83 Meyer O: Anti-CRP antibodies insystemiclupuserythematosus Joint Bone Spine 2010, 77:384-389 ... population dynamics insystemiclupuserythematosus Arthritis Rheum 2009, 60:1472-1483 52 Chung CP, Long AG, Solus JF, Rho YH, Oeser A, Raggi P, Stein CM: Adipocytokines insystemiclupus erythematosus: ...
... process insystemiclupuserythematosus (SLE) and rheumatoid arthritis (RA) even though both Gas6 and sAxl in most of the patients were within the normal range [13] Systemiclupuserythematosus ... participated inthe analysis of experimental data and inthe writing of the manuscript AJ, GS, AAB, AG, BL, EL and TS participated inthe design of the study, inthe analysis of the patient cohorts, inthe ... activity insystemiclupuserythematosus Rheumatology (Oxford) 2011, 50:1064-9 14 Katsiari CG, Liossis SN, Sfikakis PP: The pathophysiologic role of monocytes and macrophages insystemiclupus erythematosus: ...
... Mexican SystemicLupusErythematosus Disease Activity Index and theSystemicLupus International Collaborating Clinics/American Collage of Rheumatology Damage Indexes at the beginning of the study ... cytomegalovirus; SLEDAI, SystemicLupusErythematosus Disease Activity Index; SLICC, SystemicLupus International Collaborating Clinics aInformation for treatment was available in 19 patients in this group ... Snaith M, Sturfelt G: The reliability of theSystemicLupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemiclupuserythematosus Arthritis...
... PM, Isenberg DA: The effect of interleukin-10 and interleukin-12 on the in- vitro production of antidouble-stranded DNA antibodies from patients with systemiclupuserythematosus Clin Exp Immunol ... factor-α: the Janus cytokine In NZB/W F1 mice, the administration of TNF-α reduces the severity of the lupus- like illness [6] This observation has not been repeated in other lupus- prone mouse strains ... meeting showed the breadth of interest inthe role played by different cytokines in SLE A large amount of work in mice, and a smaller body of evidence on the effects of anticytokine antibodies in...
... Symmons D, Zoma A: The development and initial validation of theSystemicLupus International Collaborating Clinics/American College of Rheumatology damage index for systemiclupuserythematosus Arthritis ... protein autoantibody; CRP, C-reactive protein; mSLEDAI, modified systemiclupuserythematosus disease activity index; n.s., not significant; SLEDAI, systemiclupuserythematosus disease activity index ... environmental, and infectious risk factors for developing systemiclupuserythematosus Arthritis Rheum 1998, 41:1714-1724 Robson MG, Walport MJ: Pathogenesis of systemiclupuserythematosus Clin Exp Allergy...
... impairment insystemiclupuserythematosus Arthritis Rheum 1992, 35:411-416 Lindal E, Thorlacius S, Steinsson K, Stefansson JG: Psychiatric disorders among subjects with systemiclupuserythematosusin ... manifestations of systemiclupuserythematosus Aust N Z J Med 1988, 18:679-684 Johnson RT, Richardson EP: The neurological manifestations of systemiclupuserythematosus Medicine 1968, 47:337-369 Wekking EM: ... Psychiatric symptoms insystemiclupus erythematosus: an update Psychosom Med 1993, 55:219-228 24 25 26 27 R371 Iverson GL, McCracken LM: Attributing psychopathology to systemiclupus erythematosus: some...
... final version of the manuscript DMH assisted inthe design inthe study, inthe interpretation of the results, and in writing the final version of the manuscript DN assisted inthe design inthe ... of the results and in writing the final version of the manuscript TSM performed the plasma BLyS protein and anti-BLyS assays and assisted inthe interpretation of the results and in writing the ... 20:829-833 Ginsburg WW, Finkelman FD, Lipsky PE: Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells insystemiclupuserythematosus Clin Exp Immunol 1979, 35:76-88 Klinman DM,...
... K, Nived O, et al.: The reliability of theSystemicLupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemiclupuserythematosus Arthritis ... transforming growth factor-beta Lupus 1999, 8:95-102 Bruce IN, Gladman DD, Urowitz MB: Premature atherosclerosis insystemiclupuserythematosus Rheum Dis Clin North Am 2000, 26:257-278 Grainger ... SLE, systemiclupus erythematosus; TGF, transforming growth factor A relative Activation Index (AI) was calculated, by division of TGF-β1 levels in blood (A450) incubated at 37°C for 90 minutes...
... rates in B cell lymphomas than the agent alone [10] Such approaches also create more clinical adverse reactions and would probably not be acceptable for use in SLE Another curious finding inthe ... might be the future for epratuzumab in SLE or perhaps other autoimmune diseases? In part, the rituximab experience will determine the way, because development of that drug is much further advanced, ... hour without serious infusion reactions, and so far no major toxicities have emerged One trivial possibility is that the binding of CD22 changes little inthe organism, and thus the current randomized...
... inflammatory lesions inthe vicinity of sunburn cells (SBCs) in patients with systemiclupuserythematosus (SLE) Haepatients with systemiclupuserythematosus (SLE) matoxylin eosin (H&E)-stained ... photosensitivity insystemiclupuserythematosus Ann Rheum Dis 1989, 48:461-463 Bijl M, Limburg PC, Kallenberg CG: New insights into the pathogenesis of systemiclupuserythematosus (SLE): the role of ... apoptotic keratinocytes by macrophages inthe epidermis of patients with infiltrates (b) Representative biopsy showing CD68 staining combined with haematoxylin staining using diaminobenzidine (DAB)...